Plasticell appoints Professor Tony Cass to the Scientific Advisory Board

London, UK, 2 April 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has appointed Professor Tony Cass to its Scientific Advisory Board. Professor Cass is Professor of Chemical Biology, Deputy Director and Bio-nanotechnology Research Director in the Institute of Biomedical Engineering at Imperial College London. He is also a Founder and Executive Director of [...]

April 2nd, 2008|Press Releases|

Plasticell acquires rights to two further human embryonic stem cell lines from King’s College London

London, UK, 13 February 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has entered into an agreement with King’s College London (London, UK) to exploit and market two human embryonic stem cell (hESC) lines. hESC lines are specialized cells capable of forming all tissues of the body, and are thus a source of human [...]

February 13th, 2008|Press Releases|

Plasticell acquires rights to six human embryonic stem cell lines

London, UK, 14 January 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has entered into an agreement with Axordia Ltd (Sheffield, UK) to exploit and market a panel of six human embryonic stem cell (hESC) lines. hESC lines are specialized cells capable of forming all tissues of the body, and are thus a source [...]

January 14th, 2008|Press Releases|

Plasticell Chief Executive appointed to the Steering Committee for the UK Stem Cell Bank and for the Use of Stem Cell Lines

London, UK, 13 November 2007. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced that Dr Yen Choo, the company’s Chief Executive, has been appointed to the Steering Committee for the UK Stem Cell Bank and for the Use of Stem Cell Lines. Dr Choo is the first member of the Committee recruited from [...]

November 13th, 2007|Press Releases|

Sir Martin awarded Nobel Prize for pioneering stem cell research.

London, UK, 9 October 2007. Plasticell Ltd is delighted to note that Sir Martin Evans, a founding member of the company’s Scientific Advisory Board, has been awarded this year’s Nobel Prize in Physiology or Medicine together with Mario Capecchi and Oliver Smithies for their discoveries of "principles for introducing specific gene modifications in mice by the use of embryonic stem [...]

October 9th, 2007|Press Releases|

Plasticell and Hamilton Company announce agreement to automate high throughput stem cell differentiation technology

London, UK, 24 September 2007. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has entered into an agreement with Hamilton Company, a worldwide leader in robotic liquid handling devices and laboratory automation, to automate Plasticell’s Combinatorial Cell Culture™ technology for the determination of optimal protocols to direct stem cell differentiation. Plasticell and Hamilton will develop [...]

September 24th, 2007|Press Releases|

Plasticell to develop stem cell robotics with £1.1m funding from DTI

London, UK, 25 January 2007. Plasticell Ltd, the UK biotechnology company developing drugs to regenerate tissues of the body, announced today that it has secured a £1.1m Technology Programme grant from the Department of Trade & Industry (DTI), to support a three year collaborative research and development project entitled “A technology to ensure optimum cell performance for regenerative medicine”. Plasticell [...]

January 25th, 2007|Press Releases|

Plasticell Relocates to Imperial BioIncubator

London, UK, 2 Jan 2007. Plasticell Ltd, the UK biotechnology company developing drugs to regenerate tissues of the body, has relocated its offices and laboratories to the newly opened Imperial BioIncubator, a facility managed by Imperial Innovations and sited at Imperial College London’s South Kensington campus. Plasticell is the first external company to be admitted to the BioIncubator and joins [...]

January 2nd, 2007|Press Releases|

Plasticell Appoints Christopher Adam to the Board of Directors

London UK, 22 May 2006. Plasticell Ltd, the UK biotechnology company developing drugs to regenerate tissues of the body, has appointed Christopher Adam to its board. He will assist the company with corporate and product development strategies. Mr Adam brings over 35 years of board level and operational experience in the pharmaceutical industry to Plasticell. He has sat on the executive committee of [...]

May 22nd, 2006|Press Releases|

Plasticell secures seed financing

London, UK, 9 June 2004. Plasticell Ltd, a seed stage biotechnology company developing high throughput technology for stem cell research, today announced it has closed its first equity financing round after securing over £0.5m from angel investors including a syndicate comprising private clients of the financial services group Williams de Broë. The company will lease dedicated laboratories in the Medical [...]

June 9th, 2004|Press Releases|

Plasticell Ltd to develop innovative cell culture technology

London, UK, 1 December 2002. A UK-based, start-up biotechnology company, Plasticell Ltd, has been created to commercialise an innovative high throughput technology for cell biology. Plasticell was founded by scientist and entrepreneur Dr Yen Choo and owns intellectual property drawn to Combinatorial Cell Culture™, a bead-based high throughput screening system for the discovery of serial cell culture protocols that are [...]

December 1st, 2002|Press Releases|